Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Defeng Qing
Observed name:
D. Qing
Institution:
The People's Hospital of Guangxi Zhuang Autonomous Region
Observed institutions:
Jinan University,
The People's Hospital of Guangxi Zhuang Autonomous Region
ORCID:
0000-0001-8098-3059
Observed ORCID:
0000-0001-8098-3059
OpenAlex ID:
A5076796740
Hyperprogression After Immunotherapy for Primary Small Cell Neuroendocrine Carcinoma of the Ureter: A Case Report
2021
·
Defeng Qing
, Luxing Peng
, et al.
·
Frontiers in Oncology
·
9
PDF
MiR-30a-5p inhibits cell behaviors in esophageal cancer via modulating CBX2
2023
·
Luxing Peng
, Xinjun Huang
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
8
Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study
2020
·
Defeng Qing
, Yuying Wu
, et al.
·
Cancer Management and Research
·
5
PDF
Long-term immune checkpoint inhibitor therapy in a patient with metastatic nasopharyngeal carcinoma: a case report
2025
·
Defeng Qing
, Zhiping Lu
, et al.
·
Frontiers in Immunology
·
2
PDF
Completion of ≥6 cycles of adjuvant temozolomide is the strongest modifiable prognostic factor in glioblastoma: a 17-year real-world cohort of 319 glioma patients from a single Chinese center
2026
·
Pei Liu
, Xiaotang Xiao
, et al.
·
Frontiers in Oncology
PDF
Long-Term Results of Concurrent Chemoradiotherapy Combined With Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single Institute Prospective Study
2020
·
Y. Wu
, D. Qing
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Show more works
View as search
Works count:
6
Citation count:
24
H-index:
3
I10-index:
Year
Topic
Type